Child and Adolescent Gender Center: a multidisciplinary collaboration to improve the lives of gender nonconforming children and teens.
Pediatr Rev., Jun;33(6):273-5 (2012)
Persistent elevation of urine aquaporin-2 during water loading in a child with nephrogenic syndrome of inappropriate antidiuresis (NSIAD) caused by a R137L mutation in the V2 vasopressin receptor.
Int J Pediatr Endocrinol., 2012(1):3 (2012)
Pediatric disorders of water balance.
Pediatr. Clin. North Am., Oct;58(5):1271-80, xi-xii (2011)
Respiratory syncytial virus infection as a precipitant of thyroid storm in a previously undiagnosed case of graves' disease in a prepubertal girl.
Int J Pediatr Endocrinol., 2011:138903 (2011)
Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
Mol. Pharmacol., May;77(5):836-45 (2010)
Pediatric disorders of water balance.
Endocrinol. Metab. Clin. North Am., Dec;38(4):663-72 (2009)
Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
Clin. Endocrinol. (Oxf)., Sep;71(3):388-93 (2009)
Isolated adrenocorticotropic hormone deficiency presenting as an acute neurologic emergency in a peripubertal girl.
J. Pediatr. Endocrinol. Metab., Aug;21(8):799-803 (2008)
Statement 4: therapy should be offered to children with idiopathic short stature (ISS) whose heights are < -2.25 standard deviation (SD) score.
Pediatr Endocrinol Rev., Apr;5 Suppl 3:847-52 (2008)
Nordihydroguaiaretic acid inhibits insulin-like growth factor signaling, growth, and survival in human neuroblastoma cells.
J. Cell. Biochem., Dec;102(6):1529-41 (2007)
Report of a hÃ¼rthle cell neoplasm in a peripubertal girl.
Thyroid., Feb;17(2):175-8 (2007)
Nephrogenic syndrome of inappropriate antidiuresis (NSIAD): a paradigm for activating mutations causing endocrine dysfunction.
Pediatr Endocrinol Rev., Dec;4 Suppl 1:66-70 (2006)
Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
Am. J. Med., Jul;119(7 Suppl 1):S54-8 (2006)
Oral urea for the treatment of chronic syndrome of inappropriate antidiuresis in children.
J. Pediatr., Jan;148(1):128-31 (2006)
Nephrogenic syndrome of inappropriate antidiuresis.
N. Engl. J. Med., May;352(18):1884-90 (2005)
Akt phosphorylation is not sufficient for insulin-like growth factor-stimulated myogenin expression but must be accompanied by down-regulation of mitogen-activated protein kinase/extracellular signal-regulated kinase phosphorylation.
Endocrinology., Nov;145(11):4991-6 (2004)
Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
J. Pediatr., Oct;143(4):415-21 (2003)
Growth factor-stimulated phosphorylation of Akt and p70(S6K) is differentially inhibited by LY294002 and Wortmannin.
Endocrinology., Jan;142(1):498-501 (2001)
Long-term outcome in children and adolescents after transsphenoidal surgery for Cushing's disease.
J. Clin. Endocrinol. Metab., Oct;82(10):3196-202 (1997)
Adjunctive growth hormone during ovarian hyperstimulation increases levels of insulin-like growth factor binding proteins in follicular fluid: a randomized, placebo-controlled, cross-over study.
J. Clin. Endocrinol. Metab., Apr;82(4):1171-6 (1997)
Differential regulation of insulin-like growth factor-I (IGF-I) receptor gene expression by IGF-I and basic fibroblastic growth factor.
J. Biol. Chem., Feb;272(8):4663-70 (1997)
Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-I-induced myogenesis in rat L6E9 cells.
Endocrinology., Feb;136(2):720-6 (1995)
An insulin-like growth factor-II (IGF-II) analog with highly selective affinity for IGF-II receptors stimulates differentiation, but not IGF-I receptor down-regulation in muscle cells.
Endocrinology., Jul;135(1):38-44 (1994)
Exogenous growth hormone inhibits bovine but not murine pituitary growth hormone secretion in vitro: evidence for a direct feedback of growth hormone on the pituitary.
Neuroendocrinology., Jun;53(6):597-600 (1991)
Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II.
Mol. Endocrinol., May;5(5):709-17 (1991)
A rapid and simple one step method for isolation of poly(A)+ RNA from cells in monolayer.
Endocrinology., Oct;127(4):2038-40 (1990)
Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
J. Clin. Endocrinol. Metab., Jun;68(6):1101-5 (1989)
The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
J. Clin. Endocrinol. Metab., Oct;63(4):872-8 (1986)
Exogenous growth hormone inhibits growth hormone-releasing factor-induced growth hormone secretion in normal men.
J. Clin. Invest., Jan;77(1):176-80 (1986)
Testicular changes in gonadotropin-independent familial male sexual precocity. Familial testotoxicosis.
Arch. Pathol. Lab. Med., Nov;109(11):990-5 (1985)
Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations: familial testotoxicosis.
J. Pediatr., Jan;106(1):33-40 (1985)
Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH defic
J. Clin. Endocrinol. Metab., Jun;58(6):1043-9 (1984)
Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men.
J. Clin. Endocrinol. Metab., Sep;57(3):677-9 (1983)
Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases.
J. Clin. Endocrinol. Metab., Sep;57(3):571-9 (1983)
Renin substrate depletion in salt-losing congenital virilizing adrenal hyperplasia: low plasma renin activity despite increased renin concentration.
J. Pediatr., Jan;102(1):80-2 (1983)